Prosight Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Buy |
1,580,588
+100,588
| +7% | +$246K | 0.94% | 28 |
|
|
2025
Q1 | $9.87M | Buy |
1,480,000
+391,294
| +36% | +$2.61M | 3.24% | 12 |
|
|
2024
Q4 | $13.7M | Buy |
1,088,706
+929,337
| +583% | +$11.7M | 3.78% | 12 |
|
|
2024
Q3 | $2.94M | Buy |
+159,369
| New | +$2.94M | 0.72% | 31 |
|
|
2023
Q1 | – | Sell |
-32,193
| Closed | -$630K | – | 46 |
|
|
2022
Q4 | $630K | Sell |
32,193
-167,807
| -84% | -$3.28M | 0.34% | 32 |
|
|
2022
Q3 | $3.19M | Sell |
200,000
-76,802
| -28% | -$1.23M | 1.71% | 17 |
|
|
2022
Q2 | $3.81M | Buy |
276,802
+73,534
| +36% | +$1.01M | 3% | 13 |
|
|
2022
Q1 | $3.22M | Buy |
203,268
+74,563
| +58% | +$1.18M | 2.08% | 14 |
|
|
2021
Q4 | $2.81M | Buy |
+128,705
| New | +$2.81M | 1.68% | 18 |
|